Complete response to neoadjuvant chemoradiation therapy for esophageal cancer does not confer a survival advantage

Journal article

Peer reviewed

C Schmidt, J Tarpley, J Roberts, A Pearson, M Kelley, M Ninan, J Berlin, A Chakravarthy, R Beauchamp and N Merchant

Annals of surgical oncology, Vol.11(S2), pp.S55-S55

2004-02

Abstract

Oncology

Medicine & Public Health

Surgical Oncology

Surgery

5 Record Views

This output has contributed to the advancement of the following goals:

Source: InCites

Title: Complete response to neoadjuvant chemoradiation therapy for esophageal cancer does not confer a survival advantage
Creators: C Schmidt - Vanderbilt University Medical Center and Vanderbilt-Ingram Cancer Center Nashville IN
J Tarpley - Nashville Veterans Administration Hospital Nashville TN
J Roberts - Vanderbilt University Medical Center and Vanderbilt-Ingram Cancer Center Nashville IN
A Pearson - Vanderbilt University Medical Center and Vanderbilt-Ingram Cancer Center Nashville IN
M Kelley - Vanderbilt University Medical Center and Vanderbilt-Ingram Cancer Center Nashville IN
M Ninan - Vanderbilt University Medical Center and Vanderbilt-Ingram Cancer Center Nashville IN
J Berlin - Vanderbilt University Medical Center and Vanderbilt-Ingram Cancer Center Nashville IN
A Chakravarthy - Vanderbilt University Medical Center and Vanderbilt-Ingram Cancer Center Nashville IN
R Beauchamp - Vanderbilt University Medical Center and Vanderbilt-Ingram Cancer Center Nashville IN
N Merchant - Vanderbilt University Medical Center and Vanderbilt-Ingram Cancer Center Nashville IN
Publication Details: Annals of surgical oncology, Vol.11(S2), pp.S55-S55
Publisher: Springer-Verlag
Academic Unit: Miller School of Medicine; UMMG Department of Surgery; UMMG Dept of Dermatology & Cutaneous Surgery; UMMG Dept of Surgery - Div of Surgical Oncology
Language: English
Resource Type: Journal article
Record Identifier: 991031598323102976